Use of a Commercially Available Automated Insulin Delivery System for the Management of Type 1 Diabetes in Pregnancy
- 10 September 2024
- journal article
- letter
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 18 (6) , 1509-1510
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Continuous glucose monitoring in pregnancies with type 1 diabetes: small increases in time-in-range improve maternal and perinatal outcomesAmerican Journal of Obstetrics and Gynecology, 2024
- 7. Diabetes Technology: Standards of Care in Diabetes—2024Diabetes Care, 2023
- Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 DiabetesDiabetes Technology & Therapeutics, 2021
- Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort studyThe Lancet Diabetes & Endocrinology, 2021
- Obstetric and Perinatal Outcomes in Type 1 Diabetic PregnanciesDiabetes Care, 2009